Literature DB >> 26303691

[Influence of visceral fat area on laparoscopic radical gastrectomy in patients with gastric carcinoma].

Guanghua Fu1, Zhaojian Niu, Yanbin Zhou, Xiaobin Zhou, Hao Wang, Zhe Su.   

Abstract

OBJECTIVE: To explore the influence of visceral fat area(VFA) on laparoscopic radical gastrectomy and short-term outcome in patients with gastric carcinoma.
METHODS: Clinicopathological and imaging data of 202 patients with gastric cancer who were treated by laparoscopic radical gastrectomy in the Affiliated Hospital of Qingdao University from May 2011 to July 2014 were retrospectively analyzed. VFA of all the patients were measured by CT, of which more than 10 000 m(2) were found in 104 patients(VFA-L group), less than 10 000 m2 in other 98 patients (VFA-S group). Intraoperative and postoperative outcomes were compared between the two groups.
RESULTS: There were no differences in operation time, intraoperative blood loss and number of harvested lymph node between the two groups(all P>0.05). As compared to VFA-S group, VFA-L group had a higher incidence of conversion to open surgery[9.6%(10/104) vs. 2.0%(2/98), P=0.023], higher complication rate [22.1%(23/104) vs. 10.2%(10/98), P=0.003], longer postoperative fever time [(3.0±1.3) d vs. (2.4±1.1) d, P=0.000], total length of hospital stay [(18.6±11.8) d vs. (15.8±6.0) d, P=0.039]. There were no significant differences in first flatus passage time and total hospitalization costs between the two groups.
CONCLUSION: Elevated VFA can raise the difficulty of laparoscopic radical gastrectomy, increase the risk of postoperative complication and prolong the postoperative recovery.

Entities:  

Mesh:

Year:  2015        PMID: 26303691

Source DB:  PubMed          Journal:  Zhonghua Wei Chang Wai Ke Za Zhi        ISSN: 1671-0274


  1 in total

1.  Expression profile of cytokines in gastric cancer patients using proteomic antibody microarray.

Authors:  Xiaoqiang Quan; Yi Ding; Ruo Feng; Xiaoyan Zhu; Qinxian Zhang
Journal:  Oncol Lett       Date:  2017-09-29       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.